Genentech announced a third round of layoffs, affecting 143 jobs, as part of its strategic workforce adjustments, amid broader job cuts across various sectors in Northern California.

Those adjustments just keep coming. As SFGATE reported, Genentech announced 436 layoffs in April 2024, and 93 more layoffs ...

Reduced doses in antifibrotic therapy for patients with idiopathic pulmonary fibrosis did not significantly impact outcomes, ...

Genentech is letting go of 143 employees who are based out of the company's headquarters in South San Francisco. | Genentech ...

After enduring multiple rounds of layoffs last year, Genentech’s employees are facing more uncertainty as the Roche unit lets ...

A fresh wave of layoffs is sweeping across Northern California, with job cuts spanning the biotech, retail, agriculture and health care sectors — signaling mounting economic pressures in the region.

Lisocabtagene maraleucel significantly improved responses rates and survival outcomes among patients with relapsed or refractory chronic lymphocytic leukemia, according to findings presented at ASCO ...

The European Commission approved a tablet formulation of SMA treatment Evrysdi, a form aimed at giving patients more ...

Researchers at ASCO reviewing data from the ATOMIC trial said they will change practice based on the results but questioned ...

Genentech has announced plans to build a new biotechnology manufacturing plant in Holly Springs, North Carolina. The company, ...

HOLLY SPRINGS, N.C. (WTVD) -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs ...